Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Slovenian pharmaceutical company Krka has seen its animal health sales remain stable over 2017 with 1% year-on-year growth.
Pharmgate and Norbrook Laboratories have both received approval for generic products from the US FDA.
The UK's leading animal health company Dechra Pharmaceuticals will add to its generics expertise with the purchase of two prominent Dutch veterinary products companies.
Bulgarian animal health generics specialist Huvepharma will be able to combine its recent expansion efforts in the US with growth nearer to home following a substantial loan.
Dutch company Le Vet Pharma has continued to add to its European portfolio of generic anesthetics with its 12th and 13th product approvals of 2017.
The European Medicines Agency (EMA) has made a significant move in paving the way for more innovative animal health products by introducing its first guidance on monoclonal antibodies.
Dutch firm Le Vet Pharma has received European approval for two generic companion animal products.
The Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF) has approved products from Virbac, IDEXX Laboratories and three local companies.
The US FDA's decision to withdraw its current draft guidance for compounded animal drugs from bulk substances has come under fire from the country's animal health industry body.
The Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF) has recently approved four veterinary generics.
Dutch company Le Vet Pharma has secured decentralized European approval for its Tranquigel (acepromazine) sedative for dogs and horses.
The European Group for Generic Veterinary Products (EGGVP) has re-elected its Spanish chair Dolores Caínzos to continue leading the organization for the next three years.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.